Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.
about
Tumor angiogenesis: pericytes and maturation are not to be ignoredBreast Cancer-Associated Fibroblasts: Where We Are and Where We Need to GoTumor stroma as targets for cancer therapyUnderstanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer modelsHematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironmentBiomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosisPathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situp130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells.Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cellsFibroblast heterogeneity in the cancer wound.Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells.Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancerOverexpression of COX-2 in celecoxib-resistant breast cancer cell lines.Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer.EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factorsThe role of the microenvironment in mammary gland development and cancer.Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.Cancer associated fibroblasts and tumor growth: focus on multiple myelomaHuman breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progressionIdentification of PADI2 as a potential breast cancer biomarker and therapeutic target.COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays.Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects.Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanismsStromal cells in tumor microenvironment and breast cancerProgression of Ductal Carcinoma in Situ from the Pathological Perspective.Ductal carcinoma in situ: recent advances and future prospects.Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient PopulationCOX-2 dependent regulation of mechanotransduction in human breast cancer cellsHuman primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft modelGenetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.COX-2 modulates mammary tumor progression in response to collagen density.Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironmentp16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
P2860
Q21296683-BF7E2B83-EC30-422F-98E8-B122B26653DAQ26772925-C630373D-69AC-4970-9B7E-05C362C23FC4Q27015980-4BC26BFD-0E25-4DE3-ABB8-5C5F98A24091Q27304708-12D7CB9C-3ACC-4B10-A305-46A5A7C6F655Q28080529-FABC4D70-A7CC-4575-94CE-82F37F7D4370Q28280822-F5BE80E6-F541-4780-8D47-4111A217FB75Q29994686-E1E729D4-CBBD-4C11-8134-CD8B9935E027Q33739297-EAFB494B-1D72-4A63-801B-64388FE1901FQ33916413-3B9CC3F6-D3D4-4A22-A520-6D92FA46CD6CQ33964324-5B7E1BB5-C3A0-44D5-81B2-7DED2DC84025Q34034676-186675C7-D331-42EB-AA3E-88D249F2F3F1Q34128977-7653DC2C-262F-49EE-BF06-8C5E733D57E8Q34143022-0C40FF2B-07A5-48FE-8D5E-7BE47791D209Q34165529-CC76D21D-2007-43DA-9FF6-E491D7280465Q34203752-D2149AE0-E6BF-496F-AE7E-715777B5F4D4Q34241137-7D744F08-3927-41F3-B337-662625571E8CQ34292236-CD7AE771-E8DA-4A0E-BEA3-45FFD99A7051Q34309899-37E1AB8C-B454-4156-92FE-74FA5756952BQ34407226-186391C4-EF88-4EF2-A1B4-5CD88B7C0A2AQ34444593-85CE2381-DC94-40CD-8073-DC14689CF102Q34452014-879D17B2-27B6-4878-BDE5-33B390C29D59Q34461456-315A45C2-BFE9-4C25-A0C3-2FF0C9892B7DQ34502422-EB7B0A0B-3AB8-47F7-8EEF-8132FE208CADQ34669402-B07BB096-EED4-43D6-99E4-278FDDE3007CQ34982189-DF74534A-8165-4C37-B62A-4FDEF596F5E2Q35008863-613BC4E8-FE71-42ED-860C-C4906D13C3CAQ35186471-8D277D68-BC45-412F-9B95-6D8512EF97D7Q35426181-E20ED4EF-7FDD-4608-B31C-4A846B2DD424Q35609967-997B1678-3281-4528-B49E-AECA2F353294Q35940085-E34EC91A-05B6-49EA-986B-822071127CE9Q35996817-56877F71-887C-4EA6-B0DA-2E9B191F1315Q36014320-7A36C4D3-8132-4A9E-99C2-3C077FBD9ECCQ36023456-AE262D6B-0C83-4975-B907-148A805FDAA9Q36114823-4503E6BF-B44A-45D2-AC4A-C62041F2716DQ36214324-1EECA690-DDBC-4EA1-9DAC-D5589AA3D9ABQ36394968-53158268-5D31-4124-8C59-51F3F78BF31BQ36401953-DBA889AF-7EA7-4968-B8ED-ADDAA489B1F4Q36715145-55057511-9EA5-4908-8F8F-B53785445033Q36782365-EDA31049-7C90-4C60-A09F-D223C99BC3BBQ36921242-7495F416-A1C2-443D-B6E4-347985BA4C0F
P2860
Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@en
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@nl
type
label
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@en
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@nl
prefLabel
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@en
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@nl
P2093
P2860
P356
P1476
Role of COX-2 in epithelial-st ...... rcinoma in situ of the breast.
@en
P2093
Guillermo Peluffo
Haiyan Chen
Kornelia Polyak
Rebecca Gelman
Stuart Schnitt
P2860
P304
P356
10.1073/PNAS.0813306106
P407
P577
2009-02-13T00:00:00Z